This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...

The weight-loss drug boom has dominated headlines for the last two years — but underneath the hype lies a major flaw in the ...

GLP-1 drugs alter taste perceptions, challenging food makers to adapt by enhancing umami flavours, balancing sweetness, and ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

GH Research (NASDAQ:GHRS) is one of the best-performing NASDAQ stocks according to analysts. On June 20, GH Research announced that it had submitted a complete response to the US FDA regarding the ...